130 related articles for article (PubMed ID: 17396539)
21. Estrogen receptors in human pituitary tumors.
Burdman JA; Pauni M; Heredia Sereno GM; Bordón AE
Horm Metab Res; 2008 Aug; 40(8):524-7. PubMed ID: 18398784
[TBL] [Abstract][Full Text] [Related]
22. [Thyrotropin-secreting pituitary adenomas].
Caron P
Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
[TBL] [Abstract][Full Text] [Related]
23. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
[TBL] [Abstract][Full Text] [Related]
24. [NURSING CARE FOR A PATIENT UNDERGONE ENDONASAL ENDOSCOPIC APPROACH PITUITARY SURGERY].
Álvarez Tebar S; Jiménez Marzo R; Montes Rodríguez Mdel M; Robla Gutiérrez H
Rev Enferm; 2015 Mar; 38(3):10-4. PubMed ID: 26521405
[TBL] [Abstract][Full Text] [Related]
25. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.
Saveanu A; Jaquet P; Brue T; Barlier A
Mol Cell Endocrinol; 2008 May; 286(1-2):206-13. PubMed ID: 18241980
[TBL] [Abstract][Full Text] [Related]
26. Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report.
Andrioli M; Pecori Giraldi F; Losa M; Terreni M; Invitti C; Cavagnini F
Endocr J; 2010; 57(9):833-7. PubMed ID: 20595779
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
28. Ectopic ACTH-secreting pituitary adenoma of the sphenoid sinus: case report of endoscopic endonasal resection and systematic review of the literature.
Seltzer J; Lucas J; Commins D; Lerner O; Lerner A; Carmichael JD; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E10. PubMed ID: 25639312
[TBL] [Abstract][Full Text] [Related]
29. An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergoline.
Kunasegaran S; Croxson MS; Holdaway I; Murphy R
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784879
[TBL] [Abstract][Full Text] [Related]
30. Transsphenoidal adenomectomy.
McEwen DR
AORN J; 1995 Feb; 61(2):321-37; quiz 339-42. PubMed ID: 7717697
[TBL] [Abstract][Full Text] [Related]
31. Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide.
Cannavo S; Messina E; Albani A; Ferrau F; Barresi V; Priola S; Esposito F; Angileri F
Endocrine; 2016 Jun; 52(3):481-7. PubMed ID: 25877016
[TBL] [Abstract][Full Text] [Related]
32. Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma?
Lee EJ; Ahn JY; Noh T; Kim SH; Kim TS; Kim SH
Neurosurgery; 2009 Mar; 64(3 Suppl):ons62-9; discussion ons69-70. PubMed ID: 19240574
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
[TBL] [Abstract][Full Text] [Related]
34. Medical approach to pituitary tumors.
Neggers SJ; van der Lely AJ
Handb Clin Neurol; 2014; 124():303-16. PubMed ID: 25248595
[TBL] [Abstract][Full Text] [Related]
35. Treatment of pituitary tumours in 2014: Advances in therapy of adenomas secreting GH, ACTH and TSH.
Colao A
Nat Rev Endocrinol; 2015 Feb; 11(2):73-4. PubMed ID: 25534198
[No Abstract] [Full Text] [Related]
36. [Advances in pharmacological treatment of pituitary adenomas].
Morales Pérez FM; Díaz Peréz de Madrid J; Pérez Miranda M
An Med Interna; 1998 Sep; 15(9):490-500. PubMed ID: 10079543
[TBL] [Abstract][Full Text] [Related]
37. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
[TBL] [Abstract][Full Text] [Related]
38. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
39. Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.
Roca E; Mattogno PP; Porcelli T; Poliani L; Belotti F; Schreiber A; Maffezzoni F; Fontanella MM; Doglietto F
World Neurosurg; 2018 Jun; 114():e158-e164. PubMed ID: 29501516
[TBL] [Abstract][Full Text] [Related]
40. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
Hubina E; Nanzer AM; Hanson MR; Ciccarelli E; Losa M; Gaia D; Papotti M; Terreni MR; Khalaf S; Jordan S; Czirják S; Hanzély Z; Nagy GM; Góth MI; Grossman AB; Korbonits M
Eur J Endocrinol; 2006 Aug; 155(2):371-9. PubMed ID: 16868153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
